FDA Pharmacogenomics Advisory Committee Will Oversee Data Submissions

FDA is forming a pharmacogenomics advisory committee to handle voluntary genomic data submissions, Office of Clinical Pharmacology & Biopharmaceutics Director Lawrence Lesko, PhD, said